Kenneth J. Barr,Corey E. Bienstock,John K. Maclean,Hongjun Zhang,Richard T. Beresis,Dongshan Zhang,Neville J. Anthony,Blair T. Lapointe,Yuan Tian
申请号：
US15647437
公开号：
US10196354B2
申请日:
2017.07.12
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates to compounds according to Formula I (Formula I), and pharmaceutically acceptable salts or solvates thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.
